ClinicalTrials.Veeva

Menu

ANEURYSM@RISK: Automatic Intracranial Aneurysm Quantification and Feature Learning Modelling to Optimize Intracranial Aneurysm Rupture Prediction

U

UMC Utrecht

Status

Active, not recruiting

Conditions

Intracranial Aneurysms
Subarachnoid Hemorrhage (SAH) From Ruptured Aneurysm
Unruptured Intracranial Aneurysm

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT07111975
23U-0036_AWARE

Details and patient eligibility

About

ANEURYSM@RISK is an observational study aiming to develop and validate an artificial intelligence (AI)-based prediction model for the growth and rupture of intracranial aneurysms (IAs). By applying automated 3D segmentation and morphological quantification of IAs from MR angiography (MRA) scans, the model is intended to provide clinicians with objective and reproducible risk estimates of aneurysm instability.

The study utilizes retrospective imaging data from multiple European centers, including UMC Utrecht, AP-HP Paris, and University Medical Center Hamburg-Eppendorf (UKE). A clinical vignette study will evaluate the model's clinical utility and user experience among interventional radiologists.

This study is exempt from medical ethics review (non-WMO in the Netherlands), as it involves only existing, anonymized data and imposes no additional burden on patients.

Full description

The ANEURYSM@RISK study is part of the SHERPA project (Smart Human-centred Effortless support for Professional clinical Applications). The study aims to develop and validate a multivariable artificial intelligence (AI)-based prediction model to identify unstable unruptured intracranial aneurysms (UIAs), using morphological and clinical features.

Retrospective MR angiography (MRA) data will be collected from three clinical sites: UMC Utrecht (The Netherlands), AP-HP Paris (France), and University Medical Center Hamburg-Eppendorf (Germany). The study workflow includes:

  • Development of AI algorithms for 3D shape feature extraction after automated aneurysm segmentation
  • Training of predictive models for aneurysm growth and rupture based on morphological and clinical parameters
  • Validation of model performance using a longitudinal dataset of ~1,000 patients (target C-statistic ≥ 0.80)
  • A clinical vignette study in real-life settings to evaluate usability, decision-making impact, and inter-clinician variability

Key Performance Indicators (KPIs):

  • Discriminative performance for aneurysm instability prediction; C-statistic ≥ 0.80
  • Sensitivity ≥ 80% and specificity ≥ 50% (based on optimal cut-off values)
  • ≥ 25% reduction in time to clinical decision-making
  • ≥ 80% adherence to AI-generated suggestions by interventional radiologists
  • ≥ 20% improvement in user experience using 3D visualization compared to 2D displays (survey-based)
  • ≥ 50% reduction in inter- and intra-observer variability in aneurysm assessment

Ethical Considerations:

This is a non-interventional, retrospective study using previously acquired and anonymized imaging data. No additional procedures or data collection will be performed. The study poses no added burden or risk to patients. According to Dutch regulations, it is not subject to the Medical Research Involving Human Subjects Act (non-WMO).

Enrollment

3,800 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Available MR angiography (MRA) scans of the Circle of Willis
  • Presence of at least one intracranial aneurysm (IA)
  • Availability of follow-up imaging or clinical records indicating stability, growth, or rupture

Exclusion criteria

  • Imaging of insufficient quality for segmentation or analysis
  • Lack of follow-up data

Trial design

3,800 participants in 2 patient groups

Stable Intracranial Aneurysm Group
Description:
Participants with unruptured intracranial aneurysms (UIAs) that remained stable over time, showing no morphological growth or rupture during follow-up. Data are sourced from UMC Utrecht, UKE Hamburg, and AP-HP Paris.
Unstable Intracranial Aneurysm Group
Description:
Participants with intracranial aneurysms (IAs) that demonstrated instability over time, defined as morphological growth and/or rupture during follow-up. Data are sourced from UMC Utrecht, UKE Hamburg, and AP-HP Paris.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems